Sculptor Capital’s Protalix BioTherapeutics PLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-37,000	Closed	-$65.9K	–	313
2023 Q4	$65.9K	Hold	37,000	–	–	﹤0.01%	178
2023 Q3	$61.4K	Hold	37,000	–	–	﹤0.01%	193
2023 Q2	$74K	Buy	37,000 +17,900	+94%	+$35.8K	﹤0.01%	189
2023 Q1	$40.1K	Buy	+19,100	New	+$40.1K	﹤0.01%	298